A six-year-old girl in China died in March 2025
A six-year-old girl in China died in March 2025 after undergoing an experimental gene editing therapy at Shanghai's XinHua Hospital, reportedly due to a severe immune reaction. The treatment was part of an investigator-initiated clinical trial that did not require national regulatory approval.
Consensus
- The girl was six years old and suffered from a rare genetic mutation affecting nervous system development.
- The experimental gene editing therapy took place in March 2025 at Shanghai's XinHua Hospital.
- The girl died due to a severe immune reaction following the treatment.
- The procedure was conducted under an investigator-initiated clinical trial (IIT) program that allows local approval without national regulatory oversight.
- The number of such IITs in China increased more than 11-fold from 2015 to 2023, exceeding one thousand.
- After the incident, China tightened regulations on gene and cell therapy, restricting which hospitals can conduct trials and banning patient fees for participation.
Points of divergence
- The parents paid $860,000 to fund the research and clinical work, and were not offered compensation after the child's death. — riamo
- The hospital was fined approximately $3,600 for violations during the trial, and the lead researcher received a verbal warning. — vm
- A 2026 article in Nature reported positive results from animal trials but did not mention the child's death. — riamo
- The Nature article also failed to report cases of kidney and liver damage observed during primate experiments. — vm
Coverage (3 sources)
- A little girl died after a gene-editing experiment in China — РИАМО
- Girl dies after gene therapy in Shanghai — РИАМО
- Six-year-old girl dies in China after experimental gene therapy — Вечерняя Москва